Leist, Marcel ; Ghallab, Ahmed ; Graepel, Rabea...
Leist , M , Ghallab , A , Graepel , R , Marchan , R , Hassan , R , Bennekou , S H , Limonciel , A , Vinken , M , Schildknecht , S , Waldmann , T , Danen , E , van Ravenzwaay , B , Kamp , H , Gardner , I , Godoy , P , Bois , F Y , Braeuning , A , Reif , R , Oesch , F , Drasdo , D , Hoehme , S , Schwarz , M , Hartung , T , Braunbeck , T , Beltman , J , Vrieling , H , Sanz , F , Forsby , A , Gadaleta , D , Fisher , C , Kelm , J , Fluri , D , Ecker , G , Zdrazil , B , Terron , A , Jennings , P , van der Burg , B , Dooley , S , Meijer , A H , Willighagen , E , Martens , M , Evelo , C , Mombelli , E , Taboureau , O , Mantovani , A , Hardy , B , Koch , B , Escher , S , van Thriel , C , Cadenas , C , Kroese , D , van de Water , B & Hengstler , J G 2017 , ' Adverse outcome pathways : opportunities, limitations and open questions ' , Archives of Toxicology , vol. 91 , no. 11 , pp. 3477-3505 . https://doi.org/10.1007/s00204-017-2045-3.  , 2017